These 3 Investment Banks Could Surge in 2026. Here's Why.

Capital markets are rebounding as moderating interest rates and reduced regulatory uncertainty spur a pickup in dealmaking: EY reports M&A volume is up ~8% while total deal value surged 146% year‑over‑year, driven by megadeals, divestitures and AI‑related investments. IPO activity is also accelerating — through Sept. 30 this year deal count and proceeds matched full‑year 2024, and Q3 saw 65 IPOs raise $15.7 billion versus 40 IPOs raising $8.6 billion a year earlier — with large pending listings (e.g., SpaceX) and high backlogs. The recovery in underwriting pipelines and advisory fees should disproportionately benefit major investment banks such as JPMorgan, Goldman Sachs and Morgan Stanley.

Analysis

Market structure: Large bulge‑bracket banks (JPM, GS, MS) and equity-exchange operators stand to capture disproportionate fee pools as M&A deal value jumped ~146% YoY and IPO proceeds are matching 2024 through Sept. Large-cap banks gain pricing power on megadeals and syndication; smaller boutiques and levered PE sponsors face capacity and financing-cost constraints. A reopening of ECM increases equity supply near-term (pressuring recent IPO secondaries) while underwriting and debt issuance likely lift IG supply, nudging corporate bond spreads tighter but pushing absolute Treasury issuance sensitivity higher.

Risk assessment: Key tail risks are a 100–150bp repricing in interest rates (re-tightening financing economics), an antitrust or regulatory clampdown on mega-deals, or a major IPO failure (SpaceX delay) that dents sentiment — each could reduce fee pools 20–40% within 3–6 months. Immediate volatility will be driven by headline M&A/IPO prints (days–weeks); conversion of backlogged pipelines into mandates occurs over 3–9 months; secular AI capex underpins multi‑year growth in advisory and tech financing. Hidden dependency: underwriting capacity is capital‑constrained — bank balance sheet limits could cap fee capture if several megadeals cluster.

Trade implications: Direct plays: overweight GS (M&A share) and JPM (balance‑sheet/lead arranger) and long NDAQ exposure to higher IPO volume, sized 1–3% each, with 6–12 month horizons. Use call spreads on GS/JPM 3–9 months out (10–20% OTM) to limit downside and buy 12‑month LEAP calls on NVDA (20% OTM) to express AI backend demand. Pair trade: long GS / short MS (0.8:1) to express M&A bias vs. IPO‑heavy exposure; size modestly (net market beta neutral) and rebalance after major IPOs close.

Contrarian angles: Consensus assumes smooth conversion from backlog to fees; I see three frictions: timing clumps that cap fees, potential underwriting capital strain, and volatility in secondary pricing that could deter follow-ons. The market may be underpricing the benefit to balance‑sheet-rich banks (JPM) and overpricing headline IPO darlings (SpaceX expectations); historical 2006‑07 patterns show that megadeal waves can create short, sharp fee uplifts followed by consolidation and margin pressure. Watch for unintended consequence: a surge in leveraged buyouts raising credit stress indicators within 6–18 months.

Key Decisions for Investors

• Establish a 2% long position in GS (Goldman Sachs) with a 6–12 month horizon to capture M&A fee tailwinds; risk-manage with a stop-loss at -12% and take-profit trim at +25% or after a quarter with >10% YoY fee growth.
• Add a 1.5% long position in JPM (JPMorgan) for lead‑arranger/underwriting optionality; hedge market beta by shorting 0.5% SPX futures delta; reduce exposure if 10‑yr UST yield rises above 4.5% (trim 50%).
• Buy a 6–9 month GS call spread 10–20% OTM (long calls financed by selling further OTM calls) sized to equal 0.5% portfolio notional to express upside with defined risk; roll or unwind after major announced megadeals close.
• Allocate 1% to NVDA LEAP calls (12 months, ~20% OTM) to play AI-driven infrastructure demand that is cited as an activity driver; cap position loss to the premium paid, and exit if NVDA underperforms semis index by >15% over 3 months.
• Establish a pair trade: long NDAQ (0.8% of portfolio) vs. short MS (0.6%) to capture IPO fee flow benefiting exchanges while trimming exposure to IPO‑concentrated bankers; monitor FOMC and unwind if IPO volumes fall >30% quarter‑over‑quarter.